Back to top

Image: Bigstock

Affimed (AFMD) Catches Eye: Stock Jumps 7.2%

Read MoreHide Full Article

Affimed N.V. (AFMD - Free Report) was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 39% in the past one-month time frame.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Affimed currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%. 

Affimed N.V. Price

A better-ranked stock in the Medical – Biomedical and Genetics industry is Akcea Therapeutics, Inc (AKCA - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.1% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Affimed N.V. (AFMD) - free report >>

Akcea Therapeutics, Inc. (AKCA) - free report >>